Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.






Home » Drug Information » FDA-Approved Drugs » 1996
Medical Areas: Ophthalmology

View By: Year Company Therapeutic Areas Drug Names 

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Ocuflox (ofloxacin opthalmic solution) 0.3%

Company: Allergan
Approval Status: Approved May 1996
Treatment Area: corneal ulcers

General Information

Ocuflox has been approved for the treatment of corneal ulcers. The approval also supports the broader use of Ocuflox, which is already indicated for the treatment of bacterial conjunctivitis. Ocuflox is part of a class of anti-bacterial agents called fluoroquinolones that exhibit a broad spectrum of activity, low resistance, and favorable side-effects profile.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.